Can A New Formulation Of An Old Drug Get An SPC? European Court To Decide
Executive Summary
A case being referred to the Court of Justice of the European Union by the UK High Court is expected to clarify inconsistencies in EU case law as to whether a new formulation of an old substance is eligible for a supplementary protection certificate.
You may also be interested in...
French Court Wants EU Clarity On SPCs For New Uses
A second referral has been made to the Court of Justice of the EU on the tricky question of whether a new formulation or use of an authorized medicine can be granted its own supplementary protection certificate.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.